Close Menu

NEW YORK (GenomeWeb) – The New York State Department of Health has approved Counsyl's noninvasive prenatal screen, Prelude, which can be run as early as 10 weeks into gestation to determine the risk of fetal chromosomal aneuploidies that can cause Down syndrome and other conditions, the company announced today.

The South San Francisco, California-based genetic testing firm uses next-generation sequencing to analyze circulating cell-free DNA in maternal blood, as well as custom algorithms and bioinformatics tools.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.

 

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.